YOHIMBINE HCL maximizes the burning of stubborn fat and increases endurance by blocking alpha-2 receptors - enhances thermogenesis and intensifies metabolism. Choose Powerock Pharma for top-quality standards and proven research results.
YOHIMBINE HCL is an advanced research compound dedicated to the study of fat tissue metabolism. This compound has been designed for studies on fat tissue reduction and optimization of metabolic processes. Its action is based on blocking alpha-2 adrenergic receptors, making it a valuable tool in research on lipid metabolism and the regulation of the body's energy balance.
Explore the potential laboratory properties of YOHIMBINE HCL in the context of metabolism and energy process research.
Supports research on lipolysis processes and fat tissue metabolism.
Selective action on alpha-2 adrenergic receptors in research.
Increases metabolic activity in laboratory conditions.
Targeted action on specific areas in research.
High effectiveness in laboratory research.
Supports research on the regulation of metabolic processes.
Manufactured according to GMP, HACCP, and ISO 13485 standards.
Ensures precise results in conducted experiments.
At Powerock Pharma, our priority is to deliver only the highest quality research compounds. Each batch of Yohimbine HCL is produced in factories compliant with GMP, HACCP, and ISO 13485 standards. Our strict quality control supervision and use of the latest testing procedures ensure not only product effectiveness but also their safety and reliability. Collaboration with leading laboratories guarantees the purity and effectiveness of the compounds, ensuring consistent and repeatable results.
Yohimbine HCL should be dosed according to the research protocol. For precise dosage calculations, we recommend using the dosage calculator.
Optimal research results are obtained when taken on an empty stomach, about 30-45 minutes before the planned physical activity in the research protocol.
The suggested research period is 8-12 weeks for accurate result monitoring.
Start with 5mg per day, with the possibility of adjustment depending on the research protocol.
Start with 10mg per day, with the possibility of increasing to 20mg according to the research protocol.
Regular monitoring of cardiovascular parameters is crucial for research safety.
Tip: 1 MG = 1000 MCG
